摘要
目的回顾性分析本地区多重感染尖锐湿疣(CA)皮损人乳头瘤病毒(HPV)基因型别分布情况,比较4价和9价HPV疫苗对HPV多重感染覆盖率的差异,为防治HPV多重感染提供一定的研究数据。方法对2016年7月至2017年9月在四川省医学科学院四川省人民医院皮肤病性病研究所门诊确诊的CA患者皮损采取快速分子导流杂交聚合酶链式反应检测HPV基因型的21种亚型,选取基因型别数≥2型的患者进行统计分析。结果355例入选患者中,男性68.17%(242例),女性31.83%(113例);检出率居前五位的亚型分别为:6型52.11%(185例),11型39.44%(140例),CP8304型21.69%(77例),16型21.13%(75例),58型16.34%(58例);高危型检出率居前5位者为:16型21.13%(75例),58型16.34%(58例),39/51型15.49%(55例),52型15.21%(54例),53型13.24%(47例);仅高危型、仅低危型和高危型混合低危型感染分别占11.83%、14.65%和73.52%; 2重、3重、4重及≥5重感染的检出率分别为55.49%,25.35%,11.27%,7.89%。≤20岁、21~30岁、31~40岁、41~50岁和≥51岁各年龄组所占比例分别为5.92%、43.94%、20.00%、18.59%、11.55%。4价和9价HPV疫苗有效覆盖率分别为14.08%(50例)和30.42%(108例),差异有统计学意义(χ~2=27.385,P=0.000)。结论本地区多重感染CA患者中以2重感染及高危型混合低危型感染模式多见,低危型以6型、11型多见,高危型以16型、58型多见,9价HPV疫苗比4价疫苗对多重感染CA患者具有更好的有效覆盖率。
Objective To retrospectively analyze the genotypes distribution of human papillomavirus(HPV) multiple infection(MI) in condyloma acuminatum(CA) lesions, and compare the coverage difference between 4-valent and 9-valent HPV vaccine for HPV MI. Methods 21 subtypes of HPV were detected by the flow-through hybridization technique in the lesions of CA patients diagnosed in our department from Jul 2016 to Sep 2017. The patients with HPV genotypes ≥2 were selected for statistical analysis. Results 355 selected patients included 242 male(68.17%) and 113 female(31.83%). The top five HPV genotypes were 6 genotype(52.11%), 11 genotype(39.44%), CP8304 genotype(21.69%), 16 genotype(21.13%), and 58 genotype(16.34%). The top five high-risk HPV genotypes were 16 genotype(21.13%), 58 genotype(16.34%), 39/51 genotype(15.49%), 52 genotype(15.21%), and 53 genotype(13.24%). Only high-risk, low-risk and high-risk mixed low-risk genotypes infections accounted for 11.83%, 14.65% and 73.52% respectively. The detection rates of 2, 3, 4 and ≥5 genotypes infections were 55.49%, 25.35%, 11.27% and 7.89% respectively, while the ones among the age groups of ≤20, 21-30, 31-40, 41-50 and ≥51 years were 5.92%, 43.94%, 20.00%, 18.59% and 11.55% respectively. The effective coverage rates of 4-valent and 9-valent HPV vaccine were 14.08%(50 cases) and 30.42%(108 cases) respectively. There was a significant difference between them(SymbolcA@~2=27.385, P=0.000). Conclusion Among the CA patients with HPV MI in this area, the major infection modes are two genotypes infections and high-risk mixed low-risk genotypes infections. 6 and 11 genotypes are the most common in low-risk HPV subtypes, while 16 and 58 genotypes in high-risk ones. The 9-valent HPV vaccine has a much more coverage rate of CA patients with HPV MI than the 4-valent one.
引文
[1] 孙晔.586例宫颈疾病患者HPV检测结果分析[J].国际检验医学杂志,2015,10(12):1777-1779.
[2] 李凌佳,张胜,顾华,等.HPV感染基因型分布的回顾性分析[J].皮肤病与性病,2016,38(1):5-8.
[3] Chang L,Ci P,Shi J,et al.Distribution of genital wart human papillomavirus genotypes in China:a multi-center study[J].J Med Virol,2013(85):1765-1774.
[4] Akcali S,Goker A,Ecemis T,et al.Human papilloma virus frequency and genotype distribution in a Turkish population[J].Asian Pac J Cancer Prev,2013(14):503-506.
[5] 中华医学会皮肤性病学分会性病学组,中国医师协会皮肤科分会性病亚专业委员会.尖锐湿疣诊疗指南(2014) [J].中华皮肤科杂志,2014,47(8):598-599.
[6] 蔡文品,黄友泽,朱丰村.温州地区事业单位女职工子宫颈HPV感染的基因型分析[J].中国艾滋病性病,2016,22(5):375-377.
[7] 许召杰,邓业巍,李瑞.肛周尖锐湿疣组织HPV检测与型别分析[J].中华实验和临床病毒学杂志,2017,31(1):35-37.
[8] 李胜华,殷文浩,谭宇飞,等.嘉兴地区尖锐湿疣患者 HPV 基因分型分析[J].中国性科学,2015,24(12):53-55.
[9] 高宇,马新华,王荣跃.尖锐湿疣患者皮损中HPV的检测分型及HPV6b L1变异分析[J].中华皮肤科杂志,2010,43(5):336-338.
[10] 陈静宇,林新瑜,蔺敏.尖锐湿疣组织中人乳头瘤病毒基因型的检测[J].中国中西医结合皮肤性病学杂志,2013,12(3):140-143.
[11] 张晓梅,胡晓蕾,蒋卫平.丽水地区尖锐湿疣患者皮损HPV基因型分析[J].中国艾滋病性病,2013,19(11):838.
[12] 龚艳,王学,王绍凤,等.青岛市黄岛区人乳头瘤病毒基因类型分析[J].国际检验医学杂志,2015,36(22):3330-3332.
[13] 张钰颖,宋晓彬,郝世超,等.尖锐湿疣患者人乳头瘤病毒感染状况及影响因素研究[J].中国全科医学,2017,20(4):443-447,453.
[14] 田欣欣,王睿,姜玲波,等.山东地区1 225例男性尖锐湿疣患者HPV感染亚型分析[J].中国男科学杂志,2016,30(7):41-45.
[15] 赖秀琴.HPV分型与尖锐湿疣患者术后复发的关系研究[J].临床医学工程,2015,22(3):325-326.
[16] 余兵,肖文,赵恒光.老年尖锐湿疣患者人乳头瘤病毒基因型及复发危险因素[J].中国老年学杂志,2016,36(15):3778-3780.
[17] Takamoto D,Kawahara T,Kasuga J,et al.The analysis of human papillomavirus DNA in penile cancer tissue by hybridization[J].Oncology letters,2018,15(5):8102-8106.
[18] Araújo LA,De Paula AAP,de Paula HDSC,et al.Human papillomavirus (HPV) genotype distribution in penile carcinoma:Association with clinic pathological factors[J].PLoS One,2018,13(6):e0199557.
[19] Zhang J,Zhang Y.Prevalence of human papillomavirus and its prognostic value in vulvar cancer:A systematic review and meta-analysis[J].PLoS One,2018,13 (9):e0204162.
[20] Lu DJ,Luu M,Mita A,et al.Human papillomavirus-associated oropharyngeal cancer among patients aged 70 and older:Dramatically increased prevalence and clinical implications[J].Eur J Cancer,2018(103):195-204.
[21] Lee SA,Kang D,Seo SS,et al.Multiple HPV infection in cervical cancer screened by HPV DNA Chip TM[J].Cancer letters,2003,198(2):187-192.
[22] Noris E.Self-Assembling Plant-Derived Vaccines Against Papillomaviruses[J].Methods Mol Biol,2018(1776):85-95.
[23] 成媛媛,石梅,钱伊弘,等.上海地区男男性行为者肛门部位尖锐湿疣HPV型别特征及口腔部位HPV感染情况研究[J].中国男科学杂志,2017,31(2):22-28.